- In Bloomberg Law, Valerie Bonham Evaluates Clinical Trial Rapid Data Reporting (January 7, 2021)
- The 2020 Election and Life Sciences (December 1, 2020)
- In Law360, Attorneys Examine Change in FDA's Review Priorities for COVID-19 Lab-Developed Tests (October 22, 2020)
- In Bloomberg Law, Greg Levine Evaluates FDA Plans for Permanent COVID-19 Test Authorization (October 20, 2020)
- Greg Levine and Ed McNicholas Recognized as 2020 Washington D.C. Trailblazers by The National Law Journal (September 2, 2020)
- Life Sciences Compliance Attorneys Examine CARES Act OTC Drug Framework Overhaul (June 2, 2020)
- In MedTech Dive, Kellie Combs Examines FDA Guidance on Digital Health Devices for Treating Psychiatric Disorders (April 28, 2020)
- FDA Regulatory Chair Presents at Food and Drug Law Institute’s Webinar on FDA’s Recent COVID-19 Guidances (April 17, 2020)
- In Law360, FDA Regulatory Attorneys Examine How COVID-19 May Spur Passage of Lab Test Reform Legislation (April 8, 2020)
- Greg Levine Navigates Coronavirus Lab Test Developer Through Novel FDA Process (March 18, 2020)
- In Law360, Washington Attorneys Examine FDA & FTC Biosimilar Initiatives (February 20, 2020)
- Life Sciences Regulatory & Compliance Practice Chair Profiled in Law360 FDA Focus Column (January 22, 2020)
- In Law360, Attorneys Examine When DOJ Seeks Dismissals of Life Sciences False Claims Act Cases (December 16, 2019)
- In Bloomberg Law, Health Care Attorney Addresses Delay in Harmonizing Human Research Rules (December 16, 2019)
- Valerie Bonham Appointed to National Academy of Sciences’ Board on Life Sciences (December 10, 2019)
- In Law360, Washington Attorneys Examine U.S. Supreme Court Kisor Case for Challenges to FDA Actions (December 4, 2019)
- Ropes & Gray Attorneys to Moderate Webinar on Self-Disclosure for Grant Recipients (October 4, 2019)
- In MedTech Dive, Greg Levine Addresses FDA Guidance on Regulating Clinical Decision Support Software (October 2, 2019)
- In Bloomberg Law, Valerie Bonham Examines Foreign Influence in Federally-Funded Research (October 1, 2019)
- Life Sciences Attorneys Present at Food and Drug Law Institute Biologicals Law Course
(September 27, 2019)
- Life Sciences and Intellectual Property Practices Honored With Two LMG 2019 Life Sciences Awards (September 23, 2019)
- In Law360, Life Sciences Regulatory & Compliance Attorneys Address Drug Compounding Risks at Outsourcing Facilities (September 23, 2019)
- Valerie H. Bonham, NIH Veteran and Leader in Biomedical Research Compliance and Bioethics, Joins Ropes & Gray as Health Care Counsel (June 25, 2019)
- In Law360, Washington, D.C. Attorneys Examine Guidance on False Claims Act Cooperation Credit for Life Sciences Companies (June 19, 2019)
- In Law360, Life Sciences Attorneys Examine FDA Voluntary Recall Draft Guidance (May 30, 2019)
- In Bloomberg Law, Health Care Partner Examines Final Rule on Drugmaker TV Ad Price Disclosures (May 14, 2019)
- In Law360, Life Sciences Attorneys Examine FDA Draft Guidance on Medical Device Inspections (May 13, 2019)
- In Pink Sheet, Life Sciences Partner Discusses Drug Pre-Approval Promotion (March 28, 2019)
- Outlook 2019 Teleconference: Washington, D.C. Updates and Insights on Life Sciences and Health Care (January 23, 2018)
- Cross-Practice Team Authors Law360 Article on FDA’s Right to Try Act and Expanded Access Pathway (December 18, 2018)
- FDA Regulatory Attorney Discusses Enforcement Priorities & Whistleblower Lawsuits in Medtech Insight (November 15, 2018)
- Ropes & Gray Adds Experienced FDA Counsel in Washington, D.C. (October 22, 2018)
- Health Care Partner Addresses FDA Bid to Lower Drug Prices in The Washington Post (July 19, 2018)
- In Law360, Attorneys Examine FDA Final Guidance on Payor Communications and Communications Consistent with Labeling (June 27, 2018)
- In Inside Health Policy and Medical Marketing & Media, Life Sciences Partner Addresses FDA Final Guidance on Payor Communications and Communications Consistent with the Labeling (June 15, 2018)
- In Medical Marketing & Media, Life Sciences Partner Addresses Healthcare Marketing Changes Under Trump Administration (May 29, 2018)
- In Bloomberg Law, Life Sciences Co-Chair Addresses FDA Medical Device Clearance Proposal (April 17, 2018)
- Podcast - Developments in FDA & DOJ Regulation and Enforcement of Manufacturer Communications (April 12, 2018)
- Event - Outlook 2018 Teleconference: The Trump Administration’s Impact on Life Sciences and Health Care—the First Year
- The Latest FDA Move To Limit Digital Health Software Regs (December 22, 2017)
- FDA Issues Draft Guidances to Scale Back Regulation of Digital Health Software (December 13, 2017)
- In Law360, Life Sciences and Corporate Team Examines FDA Move to Limit Digital Software Regulations (December 22, 2017)
- FDA Issues Three Key Documents Relating to Medical Product Manufacturer Communications (January 31, 2017)
- Event - Outlook 2017: The New Administration and Its Impact on Life Sciences and Health Care (January 25, 2017)
- Health Care and FDA Changes Expected Under Trump Administration (January 11, 2017)
- “The New FDA: Product Development, Pricing and Beyond,” JD Supra Business Advisor (January 6, 2017)
- “The New U.S. Department of Health and Human Services: Tom Price and Value-Based Health Care,” JD Supra Business Advisor (January 6, 2017)
- “Life Sciences Legislation and Regulation to Watch In 2017,” Law360 (January 2, 2017)
- Podcast - The New FDA: Product Development, Pricing and Beyond (December 22, 2016)
- 21st Century Cures Act – Provisions Relating to Development Incentives for Certain Classes of Drugs (December 13, 2016)
- 21st Century Cures Act – Provisions Relating to Digital Health (December 13, 2016)
- 21st Century Cures Act – Provisions Relating to Reimbursement & Fraud and Abuse (December 13, 2016)
- 21st Century Cures Act – Provisions to Promote Drug Development (December 13, 2016)
- 21st Century Cures Act – Provisions Relating to Medical Device Innovation (December 13, 2016)
- 21st Century Cures Act – Provisions Relating to Regulation of Clinical Research (December 13, 2016)
- Podcast - FDA Holds Public Hearing on Manufacturer Communication of Scientific and Medical Information (November 14, 2016)
Cookie Settings